Lim et al. synthesized a series of 2-heteroaryl substituted benzimidazole derivatives bearing piperidinylphenyl acetamide group at 1-position and screened them for their effect on melanin-concentrating hormone (MCH), an attractive target for developing anti-obesity agents. The gene discussed is PMCH; the disease is obesity due to melanocortin 4 receptor deficiency.